Skip to content
1689-γδ T Cells Modulate Anti-Tumor Immunity episode artwork

Oct 19, 2026 20 min

1689-γδ T Cells Modulate Anti-Tumor Immunity

from Paper Talk

Recent research reveals that γδ T cells infiltrate small cell lung cancer (SCLC) tumors and lymph nodes, where they maintain functional cytotoxic profiles capable of mounting anti-tumor responses. Although conventional T cell pathways often fail in SCLC due to the downregulation of MHC-I, high levels of γδ T cells strongly predict improved clinical outcomes and prolonged overall survival when patients are treated with anti-PD-L1 immunotherapy. Furthermore, preclinical and patient-derived models demonstrate that these innate-like immune cells can be effectively redirected to destroy cancer cells through treatments like tarlatamab, while zoledronate successfully sensitizes tumors to γδ T cell-mediated killing via BTN2A1 recognition. References: Ng J, You Y, Zhang T Z, et al. γδ T cells modulate anti-tumor immunity in small cell lung cancer[J]. Cancer Cell, 2026. 前往小宇宙评论区与主播互动

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

1689-γδ T Cells Modulate Anti-Tumor Immunity

0:00 20:31

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Paper Talk?

This episode is 20 minutes long.

When was this Paper Talk episode published?

This episode was published on October 19, 2026.

Can I download this Paper Talk episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.